Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
10
|
pubmed:dateCreated |
1995-11-8
|
pubmed:abstractText |
An association found between akathisia and iron deficiency led to the suggestion that iron supplementation might be a useful therapeutic intervention for patients with akathisia. There is, however, a body of literature on the abnormal deposition of iron in the brain in several degenerative diseases like Hallervorden-Spatz syndrome, Parkinson's disease, and Alzheimer's disease. Given the ability of neuroleptics to chelate iron and promote its deposition in the brain, we questioned whether peripheral measures of iron are an accurate reflection of central iron levels and thus whether there was a rationale for iron supplementation in akathisia.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Oct
|
pubmed:issn |
0160-6689
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
56
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
476-83
|
pubmed:dateRevised |
2005-11-16
|
pubmed:meshHeading |
pubmed-meshheading:7559375-Akathisia, Drug-Induced,
pubmed-meshheading:7559375-Antipsychotic Agents,
pubmed-meshheading:7559375-Basal Ganglia,
pubmed-meshheading:7559375-Brain,
pubmed-meshheading:7559375-Dyskinesia, Drug-Induced,
pubmed-meshheading:7559375-Humans,
pubmed-meshheading:7559375-Iron,
pubmed-meshheading:7559375-Movement Disorders,
pubmed-meshheading:7559375-Parkinson Disease,
pubmed-meshheading:7559375-Receptors, Dopamine
|
pubmed:year |
1995
|
pubmed:articleTitle |
Is there a rationale for iron supplementation in the treatment of akathisia? A review of the evidence.
|
pubmed:affiliation |
Department of Psychiatry, University of Vermont College of Medicine, Burlington, USA.
|
pubmed:publicationType |
Journal Article,
Review
|